Literature DB >> 25919383

North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.

Jean Addington1, Lu Liu, Lisa Buchy, Kristin S Cadenhead, Tyrone D Cannon, Barbara A Cornblatt, Diana O Perkins, Larry J Seidman, Ming T Tsuang, Elaine F Walker, Scott W Woods, Carrie E Bearden, Daniel H Mathalon, Thomas H McGlashan.   

Abstract

In studies describing the long-term follow-up up of youth at clinical high risk (CHR) of psychosis, little attention has been given to details of specific prodromal symptoms. In this paper, we describe the prodromal symptoms of 764 CHR participants recruited in the multi-site North American Prodrome Longitudinal Study (NAPLS). Symptoms were rated on the Scale of Prodromal Symptoms (SOPS) at baseline and 6-, 12-, 18-, and 24-month follow-ups. Clinical outcome at the 2-year assessment was categorized as psychotic, prodromal progression, symptomatic or in remission. Most of the CHR sample (92%) met criteria for the attenuated positive symptoms syndrome (APSS). Significant improvements in SOPS symptoms were observed over time. Unusual thought content, disorganized communication, and overall ratings on disorganized symptoms differentiated those who transitioned to psychosis from the other clinical outcome groups. Suspiciousness and total positive symptoms differentiated those in remission from the other clinical outcome groups.

Entities:  

Mesh:

Year:  2015        PMID: 25919383      PMCID: PMC4417745          DOI: 10.1097/NMD.0000000000000290

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  21 in total

Review 1.  Prediction and prevention of psychosis in youth at clinical high risk.

Authors:  Jean Addington; Robert Heinssen
Journal:  Annu Rev Clin Psychol       Date:  2011-12-12       Impact factor: 18.561

2.  At clinical high risk for psychosis: outcome for nonconverters.

Authors:  Jean Addington; Barbara A Cornblatt; Kristin S Cadenhead; Tyrone D Cannon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Robert Heinssen
Journal:  Am J Psychiatry       Date:  2011-04-15       Impact factor: 18.112

3.  Negative symptoms in individuals at clinical high risk of psychosis.

Authors:  Danijela Piskulic; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Robert Heinssen; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Thomas H McGlashan
Journal:  Psychiatry Res       Date:  2012-03-22       Impact factor: 3.222

4.  North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment.

Authors:  Jean Addington; Kristin S Cadenhead; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Jack A Addington; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2012-10-06       Impact factor: 4.939

5.  Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk.

Authors:  Paolo Fusar-Poli; Ilaria Bonoldi; Alison R Yung; Stefan Borgwardt; Matthew J Kempton; Lucia Valmaggia; Francesco Barale; Edgardo Caverzasi; Philip McGuire
Journal:  Arch Gen Psychiatry       Date:  2012-03

6.  Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study.

Authors:  Stephan Ruhrmann; Frauke Schultze-Lutter; Raimo K R Salokangas; Markus Heinimaa; Don Linszen; Peter Dingemans; Max Birchwood; Paul Patterson; Georg Juckel; Andreas Heinz; Anthony Morrison; Shôn Lewis; Heinrich Graf von Reventlow; Joachim Klosterkötter
Journal:  Arch Gen Psychiatry       Date:  2010-03

7.  Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.

Authors:  Eva Velthorst; Dorien H Nieman; Hiske E Becker; Reinaud van de Fliert; Peter M Dingemans; Rianne Klaassen; Lieuwe de Haan; Thérèse van Amelsvoort; Don H Linszen
Journal:  Schizophr Res       Date:  2009-03-09       Impact factor: 4.939

8.  Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state.

Authors:  Frauke Schultze-Lutter; Stephan Ruhrmann; Julia Berning; Wolfgang Maier; Joachim Klosterkötter
Journal:  Schizophr Bull       Date:  2008-06-25       Impact factor: 9.306

9.  Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America.

Authors:  Tyrone D Cannon; Kristin Cadenhead; Barbara Cornblatt; Scott W Woods; Jean Addington; Elaine Walker; Larry J Seidman; Diana Perkins; Ming Tsuang; Thomas McGlashan; Robert Heinssen
Journal:  Arch Gen Psychiatry       Date:  2008-01

10.  Subclinical hallucinations in adolescent outpatients: an outcome study.

Authors:  Andor E Simon; Katja Cattapan-Ludewig; Kerstin Gruber; Jasmin Ouertani; Alexander Zimmer; Binia Roth; Emanuel Isler; Daniel Umbricht
Journal:  Schizophr Res       Date:  2009-01-22       Impact factor: 4.939

View more
  78 in total

1.  A predictive model for conversion to psychosis in clinical high-risk patients.

Authors:  Adam J Ciarleglio; Gary Brucato; Michael D Masucci; Rebecca Altschuler; Tiziano Colibazzi; Cheryl M Corcoran; Francesca M Crump; Guillermo Horga; Eugénie Lehembre-Shiah; Wei Leong; Scott A Schobel; Melanie M Wall; Lawrence H Yang; Jeffrey A Lieberman; Ragy R Girgis
Journal:  Psychol Med       Date:  2018-06-28       Impact factor: 7.723

2.  The relation of atypical antipsychotic use and stress with weight in individuals at clinical high risk for psychosis.

Authors:  Joya N Hampton; Hanan D Trotman; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Ming T Tsuang; Diana O Perkins; Larry J Seidman; Scott W Woods; Elaine F Walker
Journal:  Stress Health       Date:  2018-06-28       Impact factor: 3.519

3.  Intensive Auditory Cognitive Training Improves Verbal Memory in Adolescents and Young Adults at Clinical High Risk for Psychosis.

Authors:  Rachel Loewy; Melissa Fisher; Danielle A Schlosser; Bruno Biagianti; Barbara Stuart; Daniel H Mathalon; Sophia Vinogradov
Journal:  Schizophr Bull       Date:  2016-02-22       Impact factor: 9.306

4.  Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.

Authors:  T H Zhang; H J Li; K A Woodberry; L H Xu; Y Y Tang; Q Guo; H R Cui; X H Liu; A Chow; C B Li; K D Jiang; Z P Xiao; L J Seidman; J J Wang
Journal:  Epidemiol Psychiatr Sci       Date:  2016-04-08       Impact factor: 6.892

Review 5.  Canadian Treatment Guidelines for Individuals at Clinical High Risk of Psychosis.

Authors:  Jean Addington; Donald Addington; Sabina Abidi; Thomas Raedler; Gary Remington
Journal:  Can J Psychiatry       Date:  2017-07-21       Impact factor: 4.356

6.  Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.

Authors:  G Brucato; M D Masucci; L Y Arndt; S Ben-David; T Colibazzi; C M Corcoran; A H Crumbley; F M Crump; K E Gill; D Kimhy; A Lister; S A Schobel; L H Yang; J A Lieberman; R R Girgis
Journal:  Psychol Med       Date:  2017-03-02       Impact factor: 7.723

7.  The search for imaging biomarkers in psychiatric disorders.

Authors:  Anissa Abi-Dargham; Guillermo Horga
Journal:  Nat Med       Date:  2016-10-26       Impact factor: 53.440

8.  Age-related trajectories of social cognition in youth at clinical high risk for psychosis: An exploratory study.

Authors:  Charlie A Davidson; Danijela Piskulic; Jean Addington; Kristen S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Carrie E Bearden; Daniel H Mathalon; Scott W Woods; Jason K Johannesen
Journal:  Schizophr Res       Date:  2018-05-08       Impact factor: 4.939

9.  Schizotypal personality disorder in individuals with the Attenuated Psychosis Syndrome: Frequent co-occurrence without an increased risk for conversion to threshold psychosis.

Authors:  Anthony W Zoghbi; Joel A Bernanke; Julia Gleichman; Michael D Masucci; Cheryl M Corcoran; Allegra Califano; Justin Segovia; Tiziano Colibazzi; Michael B First; Gary Brucato; Ragy R Girgis
Journal:  J Psychiatr Res       Date:  2019-04-21       Impact factor: 4.791

10.  The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.

Authors:  Ricardo E Carrión; Andrea M Auther; Danielle McLaughlin; Ruth Olsen; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Barbara A Cornblatt
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.